Dec 17, 2021
Featuring an interview with Dr Bradley Monk, including the following topics:
Enhancing personalized medicine in advanced ovarian cancer: Overview of DNA damage repair (0:00)
Similarities and differences between PARP inhibitors; ongoing investigation of PARP inhibitors as front-line therapy for patients with ovarian cancer (4:35)
Novel agents and combinations for the management of ovarian cancers (27:25)